Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN11 | Q06124 | 3/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.31 |
| ▸ | FPR2 | P25090 | 1/20 | 0.31 |
| ▸ | THRA | P10827 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8961435 | 1.00 | PTPN11 (0.32) | PTPN11PTPN1PTPN6FPR2THRA | |
| SCHEMBL8961297 | 1.00 | PTPN11 (0.32) | PTPN11PTPN1PTPN6FPR2THRA | |
| SCHEMBL8961349 | 1.00 | PTPN11 (0.32) | PTPN11PTPN1PTPN6FPR2THRA | |
| SCHEMBL8961461 | 0.99 | FPR2 (0.31) | PTPN11FPR2SCN9A | |
| SCHEMBL8934452 | 0.97 | PTPN11 (0.34) | PTPN11PTPN1PTPN6FPR2THRA | |
| SCHEMBL8934447 | 0.97 | PTPN11 (0.34) | PTPN11PTPN1PTPN6FPR2THRA | |
| SCHEMBL8934455 | 0.97 | PTPN11 (0.34) | PTPN11PTPN1PTPN6FPR2THRA | |
| SCHEMBL8934435 | 0.97 | PTPN11 (0.34) | PTPN11PTPN1PTPN6FPR2THRA | |
| SCHEMBL8961357 | 0.96 | SCN9A (0.33) | SCN9A | |
| SCHEMBL8934436 | 0.96 | FPR2 (0.33) | PTPN11PTPN1PTPN6FPR2THRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8187494-B2 | Four- or five-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device | JNC CORPORATION (JP) | 2012-05-29 | — | — | US | disclosed |